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BACKGROUND. Although breast-conserving therapy (BCS) is considered the stand-
ard of care for early-stage breast cancer, up to 20% of patients are dissatisfied.
The effect of treatment-related factors on patient satisfaction with their health-
care experiences is unclear.
METHODS. All BCS patients at the University of Michigan Medical Center who
were treated between January 2002 and May 2006 were surveyed (n 5 714;
response rate, 79.5%). Patients were queried regarding 4 aspects of their decision
for surgery: satisfaction with the decision, decision regret, decisional conflict, and
trust in surgeons. Independent variables included the number of re-excisions, the
occurrence of postoperative complications, and postoperative breast appearance,
which was assessed by using the Breast Cancer Treatment and Outcomes scale.
Multiple logistic regression was used to assess the effect of the independent vari-
ables on each outcome controlling for demographic and clinical characteristics.
RESULTS. Breast asymmetry after BCS was correlated significantly with patient
satisfaction with their treatment experiences and patient distrust in surgeons.
Women who reported pronounced asymmetry were significantly less likely to be
satisfied with the decision for surgery compared with women who reported mini-
mal asymmetry (odds ratio [OR], 0.43; 95% confidence interval [95% CI], 0.21–
0.89). Women with pronounced asymmetry were less likely to be certain about
their surgical decision (OR, 0.36; 95% CI, 0.21–0.60) and to believe that they were
prepared to make the decision for surgery (OR, 0.25; 95% CI, 0.14–0.43). Increas-
ing breast asymmetry was associated with higher surgeon distrust scores (2.14 vs
2.30 vs 2.35; P 5 .04) and with the occurrence of postoperative complications
(distrust score: 2.23 vs 2.35; P 5 .03). Reoperation after BCS was not associated
with patient satisfaction or trust in providers.
CONCLUSIONS. Esthetic result after BCS was associated more profoundly with
aspects of satisfaction than either surgical therapy or the occurrence of post-
operative complications. The current findings indicated that surgeons who care
for patients with breast cancer should identify the women at an increased risk
for breast asymmetry preoperatively to effectively address their expectations of
treatment outcomes. Cancer 2008;112:1679–87.  2008 American Cancer Society.
KEYWORDS: breast cancer, surgery, patient satisfaction, patient-provider interac-
tion, esthetic outcome.
R ecent healthcare policy has focused increasingly on developingappropriate measures of quality for breast cancer care. For
patients with breast cancer, patient-centered outcomes, such as
satisfaction with care, are important indicators of quality. Many
patients have a choice between mastectomy and breast-conserving
surgery (BCS), and the long-term survival after surgery is excellent.1
Therefore, understanding the factors related to patient satisfaction
with care is paramount to optimizing healthcare for these patients.
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It often is assumed that choosing BCS will lead
to increasing patient satisfaction, because mastec-
tomy is associated with more disfigurement and
morbidity compared with lumpectomy.2,3 However,
recent literature suggests that other aspects of care
during consultation are more important than the
type of surgery alone. These include patient involve-
ment in the decision for surgery, surgeon specializa-
tion in breast surgery, and access to informational
materials.4–6 However, much less is known regarding
the effect of treatment-related outcomes on patient
satisfaction. For example, approximately 50% of
women will require re-excision lumpectomy, and
postoperative asymmetry is common.7–11 The occur-
rence of postoperative complications can increase
the cost and morbidity associated with care and can
delay the initiation of adjuvant therapy. Therefore, a
more thorough understanding of the effects of post-
operative outcomes after BCS on patient satisfaction
with care can inform strategies to improve the qual-
ity of breast cancer care. To study this issue, we sur-
veyed women undergoing BCS at our institution to
evaluate the effect of 1) esthetic outcome, 2) need
for re-excision or mastectomy after BCS, and 3)
occurrence of postoperative complications on patient
satisfaction with the treatment experience and
patient trust in providers.
MATERIALS AND METHODS
Study Population
Patients who underwent BCS between January 2002
and May 2006 at the University of Michigan Medical
Center for a diagnosis of breast cancer were identi-
fied for the study (n 5 898). All women in this sam-
ple underwent their cancer surgery at the University
of Michigan. Patients at this center are evaluated in a
multidisciplinary clinic and receive both an educa-
tional video and written materials regarding surgical
treatment, chemotherapy, and radiotherapy for breast
cancer. Patients were mailed a survey using the Dill-
man method along with a small cash incentive.12,13
Of the eligible patients, 714 responded to the survey
(response rate, 79.5%). The study protocol was
approved by the Institutional Review Board at the
University of Michigan.
Dependent Variables
We selected 4 measures of patient satisfaction with
their treatment experience: satisfaction with the deci-
sion for surgery, regret with the decision for surgery,
conflict with the decision for surgery, and patient
trust in physicians. To measure satisfaction with the
decision for surgery, we used items from the
Holmes-Rovner Satisfaction with Decision Making
Scale,14 which developed to measure satisfaction
with healthcare decisions in the context of post-
menopausal hormone-replacement therapy deci-
sions. The 6-item scale has excellent reliability
(Cronbach a, .86) and has been used extensively to
evaluate satisfaction with the decision for breast can-
cer surgery.4,6,14–16 To measure decisional regret after
the decision for surgery, we used items from the De-
cision Regret Scale.17 This 5-item scale has excellent
reliability (Cronbach a, .81–0.92) and is well corre-
lated with decision satisfaction, decisional conflict,
and overall rated quality of life. Decisional conflict
was measured by using a 15-item Decisional Conflict
scale,18 which was developed to understand uncer-
tainty and regret among patients making healthcare
decisions. The items included in this scale are reli-
able (Cronbach a, .81), and the scale is modified eas-
ily for use in the breast cancer patient population.
Along this scale, 3 subsets are identified: certainty
with the decision for surgery, feeling equipped to
make the decision for surgery, and feeling effective in
the decision-making process. In addition, patient
trust in providers was measured by using an 11-item
scale,19 the Hall Trust in Physicians Scale, which was
developed to measure patient trust in physicians.
This instrument has been used previously in rheu-
matoid arthritis patients and general internal medi-
cine ambulatory patients with excellent reliability
(Cronbach a, .89).
All items were answered on a 5-point Likert scale
(strongly agree to strongly disagree) to measure the
patient’s level of agreement with each statement. For
each of the domains of patient satisfaction detailed
above, scales were created by averaging responses to
generate a response score. Then, scores were dichot-
omized: Scores 4 were categorized as satisfied, and
scores <4 were categorized as dissatisfied.
Independent Variables
The independent variables of interest included the
following: 1) breast asymmetry, 2) the need for re-
excision or mastectomy after initial BCS attempt,
and 3) the occurrence of postoperative complica-
tions. Postoperative breast asymmetry was assessed
by patient response to items from the Breast Cancer
Treatment and Outcomes Survey.20 Patients also were
asked to rate differences in breast skin color. Answers
to each item were rated on a 4-point scale (1, no dif-
ference between breasts; 2, slight difference between
breasts; 3, moderate difference between breasts; and
4, large difference between breasts). Responses were
summed to generate an overall asymmetry score.
Response scores were categorized into 3 groups:
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minimal asymmetry (scores 15), moderate asym-
metry (scores from 15 to 20), and high asymmetry
(scores >20).
Information regarding surgical procedure was
obtained from a review of the medical record. Re-
excision lumpectomy was classified as any further
operation after either an excisional biopsy or lum-
pectomy or if it was recorded as a re-excision
lumpectomy in the surgical report. Information con-
cerning the receipt of axillary lymph node dissection
(ALND) and of neoadjuvant chemotherapy adminis-
tration was obtained by patient report. Procedures
that were performed for immediate postoperative
complications, such as hematoma or seroma evacua-
tion, were not included in this definition. Information
on the occurrence of postoperative complications
(bleeding, wound complications requiring return to
the operating room, thromboembolic phenomena,
infection requiring antibiotic therapy, and seroma)
was obtained by patient report in the mailed survey
and was confirmed by medical record review.
Tumor stage also was included in this analysis
based on the sixth edition of the American Joint
Commission on Cancer Coding and Staging Manual
and was obtained by report to the University of
Michigan Cancer Registry. Women who were treated
before January 1, 2003 were staged according to the
fifth edition of the American Joint Commission on
Cancer Coding and Staging Manual. Information on
the receipt of radiotherapy was obtained by patient
report on the mailed survey. Patient demographic in-
formation (age at the time of diagnosis, time from
surgery in years, ethnicity, marital status, and level of
education) was self-reported.
Statistical Analysis
We used descriptive statistics to display the charac-
teristics of the patient sample. For 3 of our out-
comes, satisfaction with the decision for surgery,
decisional regret, and decisional conflict, patient
scores were highly skewed toward increased satisfac-
tion. Therefore, we dichotomized response scores for
these outcomes, with scores 2 categorized as satis-
fied and scores 2.1 categorized as dissatisfied.
Scores of patient trust were distributed normally;
therefore, we elected to analyze these responses on a
continuous scale. We tested the correlations between
each dependent variable and each independent vari-
able by using chi-square tests and Student t tests to
generate univariate statistics. Then, we used logistic
regression to generate odds ratios to determine the
correlation between our independent variables and
our outcomes of patient satisfaction after including
the patient demographic variables (age, education,
race, and marital status) and clinical variables (tumor
stage, receipt of radiotherapy, timing of chemother-
apy, receipt of ALND, and time from surgery
received) in the model. We used linear regression to
predict adjusted scores of patient trust after includ-
ing the patient demographic variables (age, educa-
tion, race, and marital status) and clinical variables
(tumor stage, receipt of radiotherapy, timing of
chemotherapy, receipt of ALND, and time from sur-
gery received) in the model. All models were exam-
ined for multicollinearity. Second-order interactions
were tested, but no significant interactions were
observed. Wald tests were used to test for differences
in group variables. All P values <.05 were considered
statistically significant. All analyses were performed
by using Stata release 9.0 (Stata Corp., College
Station, Tex).
RESULTS
Table 1 lists the demographic characteristics of our
study sample. The majority of women were Cauca-
sian (90.3%), 77.2% of women had attended some
college or were college graduates, 56.1% of the sam-
ple had annual incomes that exceeded $60,000, and
74% were married. In addition, 10.1% of women
were aged 40 years, 27.8% were aged 41 to 50 years,
34.4% were aged 51 to 60 years, 17.6% were aged 61
to 70 years, and 10.2% were aged 71 years.
Table 2 lists the clinical characteristics of the
study patients. Of these patients, 44.9% underwent
only 1 lumpectomy, 43.3% required 2 excisions, and
11.8% underwent 3 tumor excisions. Ultimately,
TABLE 1
Demographic Characteristics of the Study Population
Characteristic No. of patients %
Race
Caucasian 626 90.3
African American 37 5.3
Other 30 4.3
Education
High school or less 153 22.7
Some college 227 33.7
College graduates or beyond 293 43.5
Marital status
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10.8% of women underwent a mastectomy after an
initial attempt at breast conservation. The majority
of women in the sample (86.7%) underwent radio-
therapy, and 67.8% had either carcinoma in situ or
stage I disease. Overall, 24.3% of women reported
experiencing a postoperative complication, and the
most common complications reported were infection
(13%) and seroma (14.2%). For the breast asymmetry
variable, 35.9% of women reported minimal breast
asymmetry, 33.5% reported moderate breast as-
ymmetry, and 30.6% reported pronounced breast
asymmetry.
Table 3 details the rates of satisfaction in the
study sample. Overall, rates of satisfaction were high
across each outcome, and few patients reported deci-
sional regret. In this sample, 86.5% of patients
reported satisfaction with the decision for surgery,
and only 13.5% reported regret with their decision.
For aspects of decisional conflict, 55.6% of women
reported feeling certainty with the decision for sur-
gery, 61.6% reported feeling prepared for the decision
for surgery, and 87.1% reported feeling effective in
the decision-making process. The mean surgeon dis-
trust score in the sample was 2.24 (range, 1–4.8).
Tables 4 through 7 detail the association of
breast asymmetry, the number of procedures, and
the occurrence of postoperative complications and
satisfaction with the treatment experience, control-
ling for clinical and demographic characteristics.
There was a significant correlation between breast
asymmetry and patient satisfaction with their treat-
ment experiences and patient distrust in surgeons.
Women who reported pronounced breast asymmetry
were significantly less likely to be satisfied with the
decision for surgery compared with women who
reported minimal breast asymmetry (moderate asym-
metry: odds ratio [OR], 0.74; 95% confidence interval
[95%CI], 0.35–1.57; pronounced asymmetry: OR, 0.43;
95%CI, 0.21–0.89; Wald test, 5.81; P 5 .06) (Table 4).
Other clinical and demographic variables were not
correlated significantly with satisfaction with the de-
cision for surgery.
Breast asymmetry also was correlated with
aspects of decisional conflict in multivariate analysis
(Table 5). Women with pronounced breast asymme-
try were less likely to report feeling certain concern-
ing the decision for surgery compared with women
who experienced little breast asymmetry (moderate
asymmetry: OR, 0.57; 95%CI, 0.34–0.94; pronounced
asymmetry: OR, 0.36; 95%CI, 0.21–0.60; Wald test,
TABLE 2
Clinical Characteristics of the Study Population
Characteristic No. of patients %
Surgical therapy
1 excision 316 44.9
2 excisions 305 43.3
3 excisions 83 11.8




In situ disease 150 21.3
I 327 46.5
II 190 27
III or IV 37 5.3
Postoperative complications
Hemorrhage 25 3.7

















No chemotherapy or adjuvant chemotherapy 605 90.3
Neoadjuvant chemotherapy 65 9.7
ALND indicates axillary lymph node dissection.
TABLE 3
Satisfaction With the Decision for Surgery, Decisional Conflict,
Decisional Regret, and Trust in Surgeons Among Women
Undergoing Breast-conserving Surgery
Variable No. of patients %
The decision for surgery
Satisfied 603 86.5
Dissatisfied 94 13.5
Conflict with the decision for surgery
Certain with the decision for surgery
Yes 384 55.57
No 307 44.43
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15.1; P < .001), and they were less likely to report
feeling prepared for the decision for surgery (mod-
erate asymmetry: OR, 0.40; 95%CI, 0.23–0.69; pro-
nounced asymmetry: OR, 0.25; 95%CI, 0.14–0.43;
Wald test, 24.4; P < .009). Women with more pro-
nounced breast asymmetry also were less likely to
report feeling that they were effective in the deci-
sion-making process, although this trend did not
reach statistical significance. In addition, women
aged <40 years were less likely than women ages 51
to 60 years to be certain about their decision for sur-
gery (OR, 0.37; 95%CI, 0.18–0.79).
Women who experienced pronounced breast
asymmetry were more likely to experience regret with
their decision for surgery compared with women who
experienced minimal asymmetry (moderate asymme-
try: OR, 2.27; 95%CI, 1.01–5.12; pronounced asymme-
try: OR, 4.13; 95%CI, 1.85–9.19; Wald test, 12.41;
P 5 .002) (Table 6). Breast asymmetry and the occur-
rence of postoperative complications also were corre-
lated significantly with distrust of surgeons after
controlling for other factors (Table 7).
Women with increasing breast asymmetry were
more likely to report distrust of their surgeons com-
pared with women who experienced little asymmetry
(distrust scores: 2.14 vs 2.30 vs 2.35; P 5 .04), and
women who experienced postoperative complications
reported higher distrust scores compared with
patients who did not (2.23 vs 2.35; P 5 .03). In addi-
tion, women who underwent 2 surgical excisions
reported higher distrust scores compared with women
who required only 1 excisions (2.36 vs 2.21; P 5 .05).
DISCUSSION
In our sample of women who underwent BCS, breast
asymmetry and patient satisfaction with care were
correlated significantly. Increasing breast asymmetry
was correlated with patient-reported regret and dis-
satisfaction with the decision for surgery. Breast
asymmetry also was correlated significantly with
higher levels of decisional conflict. Overall, the
occurrence of postoperative complications, the need
for 2 surgical excisions, and postoperative breast
asymmetry all were associated with increasing levels
of patient distrust of surgeons.
Although it is clear that esthetic outcomes play
an important role in the patient treatment experi-
ence, the mechanisms underlying this association are
not well understood. Women with more breast asym-
metry may believe that their expectations for surgery
were not met. Patient satisfaction is highly depend-
ent on the extent to which postoperative outcomes
match preoperative expectations, and previous litera-
TABLE 4
Patient Satisfaction With the Decision to Undergo Surgery Among
Women Undergoing Breast-conserving Surgery
Characteristic
Odds of satisfaction with the




African American 2.91 (0.34–24.9)
Other 1.71 (0.36–8.10)
Wald test 1.39 (P = .50)
Education
High school or less 1.21 (0.54–2.72)
Some college 1.09 (0.57–2.07)
College graduates or beyond* —
Wald test 0.22 (P = .90)
Marital status
Married or partnered* —











2 excisions 0.97 (0.53–1.76)
Mastectomy 2.56 (0.75–8.66)













In situ disease* —
I 1.44 (0.48–4.37)
II 0.97 (0.28–3.34)
III or IV 1.25 (0.24–6.35)
Wald test 1.27 (P = .74)











95% CI indicates 95% confidence interval; ALND, axillary lymph node dissection.
* Reference group.
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ture indicates that women who receive educational
tools are more satisfied with outcomes and perceive
that they are more informed about their treat-
ment.21–23 Women who are dissatisfied with their
breast appearance after BCS may perceive that they
did not participate in the decision for surgery to the
extent that they desired. Matching patient involve-
ment in the decision for surgery to their desired level
can improve patient satisfaction with the treatment
experience and trust in providers.4,24–26 Patients who
participate in the decision for surgery may be
informed more adequately about the surgical proce-
TABLE 5
Patient Satisfaction With Decision Making Among Women Undergoing Breast-conserving Surgery
Conflict with the decision for surgery
Odds of feeling certain
with the decision for
surgery (95%CI)
Odds of feeling prepared
for the decision for
surgery (95%CI)
Odds of feeling




Caucasian* — — —
African American 0.78 (0.26–2.37) 1.64 (0.51–5.23) *
Other 1.06 (0.38–2.93) 0.79 (0.28–2.20) 1.75 (0.36–8.50)
Wald test [P] 0.20 [.91] 0.90 [.64] 0.49 [.49]
Education
High school or less 0.74 (0.42–1.29) 0.70 (0.39–1.25) 1.82 (0.75–4.41)
Some college 1.17 (0.73–1.86) 0.82 (0.51–1.33) 1.44 (0.74–2.80)
College graduates or beyond* — —
Wald test [P] 2.39 [.30] 1.60 [.45] 2.28 [.32]
Marital status
Married or partnered* — —
Not partnered 0.71 (0.44–1.14) 0.64 (0.39–1.04) 0.80 (0.40–1.58)
Age, y
40 0.37 (0.18–0.79) 0.72 (0.34–1.56) 0.62 (0.24–1.59)
41–50 0.89 (0.54–1.49) 1.16 (0.68–1.99) 0.80 (0.40–1.63)
51–60* — — —
61–70 0.96 (0.53–1.74) 0.71 (0.39–1.30) 1.79 (0.67–4.80)
71 0.96 (0.45–2.04) 0.65 (0.30–1.41) 1.80 (0.48–6.83)
Wald test 6.97 (P 5 0.14) 4.01 (P 5 0.40) 4.48 (P 5 0.34)
Clinical characteristics
No. of excisions 1 excision* — — —
2 excisions 1.24 (0.80–1.91) 0.81 (0.52–1.28) 0.96 (0.52–1.80)
Mastectomy 1.33 (0.59–2.98) 1.69 (0.72–3.99) 1.80 (0.54–6.00)
Wald test 1.08 (P 5 0.58) 3.12 (P 5 0.21) 1.05 (P 5 0.59)
Breast asymmetry Minimal* — — —
Moderate 0.57 (0.34–0.94) 0.40 (0.23–0.69) 0.70 (0.32–1.54)
Pronounced 0.36 (0.21–0.60) 0.25 (0.14–0.43) 0.46 (0.22–0.99)
Wald test 15.10 (P < 0.001) 24.43 (P < 0.001) 4.23 (P 5 0.12)
Postoperative complication No* — — —
Yes 1.20 (0.75–1.92) 1.45 (0.89–2.36) 0.77 (0.41–1.46)
Received radiotherapy Yes* — — —
No 3.47 (1.53–7.88) 3.25 (1.40–7.52) 1.02 (0.29–3.62)
Disease stage In situ disease* — — —
I 0.90 (0.40–2.05) 1.06 (0.46–2.45) 1.68 (0.56–5.02)
II 0.62 (0.26–1.46) 0.77 (0.32–1.84) 1.57 (0.50–4.95)
III or IV 0.40 (0.13–1.28) 0.41 (0.13–1.33) 0.94 (0.21–4.12)
Wald test 4.04 (P 5 0.26) 4.08 (P 5 0.25) 1.68 (P 5 0.64)
Time from surgery, y 1* — — —
2–3 1.08 (0.68–1.73) 1.43 (0.88–2.32) 0.55 (0.27–1.11)
4 1.19 (0.69–2.06) 1.52 (0.86–2.67) 0.67 (0.29–1.56)
Wald test 0.39 (P 5 0.82) 2.85 (P 5 0.24) 2.79 (P 5 0.25)
Received ALND No* — — —
Yes 1.59 (0.90–2.84) 1.32 (0.73–2.39) 0.62 (0.28–1.36)
Neoadjuvant chemotherapy No* — — —
Yes 0.82 (0.42–1.60) 1.36 (0.67–2.78) 1.78 (0.66–4.80)
95% CI indicates 95% confidence interval; ALND, axillary lymph node dissection.
* Reference group.
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dure and may have more realistic expectations
regarding the esthetic result.
Another possible explanation for the associations
we observed is that poor esthetic outcomes result in
greater postoperative psychological burden. Previous
studies suggested that poor esthetic results after sur-
gery were correlated with increased anxiety, depres-
sion, and dissatisfaction with body image.27 It is
interesting to note that the majority of women who
chose mastectomy and did not have a clinical con-
traindication to BCS reported that they were involved
in the surgical treatment decision and that their sur-
geon favored BCS. Although this may appear coun-
terintuitive given recent efforts by professional
organizations to define BCS as the standard of care,
patients may desire mastectomy because they have a
TABLE 6
Decision Regret Among Women Undergoing Breast-conserving Surgery






African American 1.04 (0.26–4.17)
Other 0.72 (0.15–3.49)
Wald test 0.17 (P 5 0.92)
Education High school or less 1.18 (0.54–2.59)
Some college 1.13 (0.59–2.16)
College graduates or beyond* —
Wald test 0.22 (P 5 0.89)
Marital status Married or partnered* —
Not partnered 1.29 (0.67–2.48)





Wald test 2.13 (P 5 0.71)
Clinical characteristics
No. of excisions 1 excision* —
2 excisions 0.99 (0.54–1.81)
Mastectomy 0.44 (0.14–1.38)
Wald test 2.09 (P 5 0.35)
Breast asymmetry Minimal* —
Moderate 2.27 (1.01–5.12)
Pronounced 4.13 (1.85–9.19)
Wald test 12.41 (P 5 0.002)
Postoperative complication No* —
Yes 0.99 (0.53–1.85)
Received radiotherapy Yes* —
No 0.37 (0.13–1.08)
Disease stage In situ disease* —
I 1.07 (0.33–3.53)
II 1.66 (0.50–5.54)
III or IV 1.52 (0.32–7.25)
Wald test 1.68 (P 5 0.64)
Time from surgery, y 1* —
2–3 0.88 (0.46–1.69)
4 0.97 (0.45–2.05)
Wald test 0.17 (P 5 0.92)
Received ALND No* —
Yes 0.81 (0.38–1.72)
Neoadjuvant chemotherapy No* —
Yes 1.26 (0.49–3.20)
95% CI indicates 95% confidence interval; ALND, axillary lymph node dissection.
* Reference group.
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fear of adjuvant therapy, such as radiation, and con-
cerns regarding long-term survival and disease recur-
rence.28 In addition, other studies have demonstrated
that women who underwent mastectomy with auto-
logous tissue reconstruction achieved a superior es-
thetic result compared with women who underwent
BCS alone.29 Surgeons may not be fully aware of the
psychosocial and esthetic burden of BCS on patients
in the long-term recovery period and its effect on
postoperative quality of life.
The current study has several notable limitations.
Because the patient sample was drawn from a tertiary
care center, our results may not be generalizable to
women who are cared for at other facilities. In addi-
tion, our study sample was relatively homogenous
with respect to sociodemographic characteristics.
Therefore, we may have been unable to capture im-
portant differences in patient satisfaction by ethnicity
and economic factors. Third, although we achieved an
excellent response rate, nonresponders did differ
slightly with respect to race and receipt of re-excision.
Compared with responders, nonresponders were more
likely to be nonwhite and were less likely to have
undergone re-excision lumpectomy. Finally, we sur-
veyed patients retrospectively, and patients’ recollec-
tion of their experience may change over time.
However, controlling for the time from diagnosis in
our analysis did not change our results substantially.
Despite these limitations, these results under-
score the importance of effective provider-patient
communication during the consultation for breast
cancer surgery. The Accreditation Council for Gradu-
ate Medical Education now lists interpersonal com-
munication skills as 1 of the 6 core competencies in
physician training.30 A recent analysis by the Ameri-
can College of Surgeons revealed that nearly 20% of
liability claims are a result of communication break-
downs between patients and providers.31 Such efforts
by professional organizations signal the importance
of communication to ensure that patients receive
optimal care by their physicians. Our results suggest
that patients may not anticipate the extent of asym-
metry that can occur after BCS, and this may lead to
a sense of regret, dissatisfaction, and distrust of the
treatment experience. Surgeons who are caring for
patients with breast cancer should identify women
who are at an increased risk for breast asymmetry or
complication after BCS preoperatively to address
their expectations of treatment outcomes as realisti-
cally as possible.
In conclusion, the majority of women with a di-
agnosis of breast cancer have a choice between mas-
tectomy and BCS. Patients choose BCS for different
reasons, such as faster surgical recovery and less
TABLE 7
Trust in Surgeons Among Women Undergoing Breast-conserving
Surgeryy




African American 2.11 .346
Other 1.92 .03
Wald test 2.75 .07
Education
High school or less 2.10 .02
Some college 2.28 .64
College graduates or beyond* 2.32 —
Wald test 2.79 .06
Marital status
Married or partnered* 2.23 —







Wald test 0.33 .86
Clinical characteristics
No. of excisions
1 excision* 2.21 —
2 excisions 2.36 .05
Mastectomy 2.12 .44













In situ disease* 2.25 —
I 2.27 .90
II 2.26 .96
III or IV 2.27 .94
Wald test 0.01 1.0











95% CI indicates 95% confidence interval; ALND, axillary lymph node dissection.
* Reference group
y Higher scores indicate greater patient distrust.
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postoperative disfigurement. Although women may
opt for BCS because it preserves breast size and
shape, our findings suggest that patients may be
more tolerant of a surgical complication or repeat
operation as long as esthetic expectations are met.
Breast asymmetry is common after BCS, but many
surgeons underestimate the impact of breast appear-
ance on patient satisfaction. Meeting patient expec-
tations and facilitating communication between
patients and providers is important to ensure that
patients make an informed choice for surgery.
Women who opt for breast conservation should be
aware of the prevalence of breast asymmetry after
BCS, and efforts should be made to develop educa-
tional tools that incorporate reconstructive options
for all women undergoing breast surgery. Such strate-
gies to improve patient satisfaction ultimately will
improve the quality of breast cancer care.
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